Skip to main content

Peer Review reports

From: Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis

Original Submission
27 Jul 2022 Submitted Original manuscript
11 Oct 2022 Reviewed Reviewer Report
28 Oct 2022 Reviewed Reviewer Report
2 Nov 2022 Reviewed Reviewer Report
26 Dec 2022 Author responded Author comments - Miwa Kawanaka
Resubmission - Version 2
26 Dec 2022 Submitted Manuscript version 2
2 Jan 2023 Author responded Author comments - Miwa Kawanaka
Resubmission - Version 3
2 Jan 2023 Submitted Manuscript version 3
20 Apr 2023 Reviewed Reviewer Report
23 Apr 2023 Reviewed Reviewer Report
23 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Apr 2023 Editorially accepted
10 May 2023 Article published 10.1186/s12876-023-02786-4

You can find further information about peer review here.

Back to article page